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breast cancer survivors: a systematic review
editorial—looking back to move ahead
G. A. Bachmann* and S. Ramachandra
This comprehensive review of sexual dysfunction in
breast cancer survivors (BCS’s) by Su et al., is a must
read for all clinicians who care for not only midlife
women who have had breast cancer, but for all women
who have had a breast cancer diagnosis, regardless of
their age. From these data, although the authors are able
to offer useful management strategies, it is clear that
there are many opportunities for evaluating current
options and exploring future ones for BCS’s with sexual
dysfunction. As the authors note, there is still a ‘clinical
trials’ road ahead of us that remains to be tread if we are
toidentify effective interventions supported by high quality
evidence that ultimately will assist BCS’s with their sexual
issues and improve their sexual interest, maintain their
orgasmic ability and ameliorate or eliminate their genito-
pelvic pain. What was particularly striking about this
extensive literature review was the authors’ recommenda-
tion that educational and counseling interventions be
included in both the clinical management of the BCS with
sexual dysfunction and in clinical trials evaluating pre-
scription and OTC pharmacologic interventions aimed to
improve or eliminate sexual dysfunction.
The recommendation of face-time with the patient rein-
forces much of the ground breaking work done by pio-
neers in the field of sexual medicine—namely, that sexual
dysfunction is multidimensional in origin and that each
woman will present with unique circumstances and needs
that will demand different approaches and at times multi-
faceted treatment strategies. Let’s take a short journey
back over the past few decades with some examples that
reinforce what this review by Su et. al suggest—that edu-
cation and counseling strategies be provided to the BCS
and be included in clinical trials. The reason one-on-one/
group education/counseling interventions with patients is
critical in patient care and in the evaluation of the safety
and efficacy of management strategies in the research set-
ting can be attributed to the psychological, social, cultural,
financial and inter- and intrapersonal relationship issues
that impact sexual health and wellness. Focusing on BCS’s,
the major areas that will adversely impact their sexual
function and should be addressed include the woman’s re-
action (and her clinician’s) to the diagnosis of the cancer
itself, the body alterations that are necessitated by the
breast cancer treatment and the new role of ‘patient’ that
the otherwise healthy women is suddenly catapulted into.
First, the diagnosis of breast cancer and its overall
meaning to the woman (and, when there is one, her sexual
partner) and her clinician must be addressed when dealing
with the patient and in studying a particular pharmaco-
logic intervention. Early sexual health thought leaders
clearly spelled out that the management of sexual dysfunc-
tion, especially in BCS’s must encompass the impact of
the cancer on both the patient/couple and, not surpris-
ingly, her treating clinician. Over 30 years ago, the text-
book, Sexual Problems in Medical Practice, (edited by
Harold Lief, MD) contains many of the elements critical
to addressing sexual issues in patients, including the pa-
tient’s and clinician’s reaction to the cancer diagnosis [1].
As stated in this text, the physician has to keep the
woman’s sexual health a priority throughout the breast
cancer treatment as well as afterwards and not dismiss
this aspect of the patient’s life as unimportant. Levay,
Sharpe and Kagle, as referenced in this text, further noted,
that cancer in general “…is associated with disfigurement
after surgery, long and painful illness and high prob-
ability of death. It is not surprising that physicians often
give the patient’s sexual life low priority” [2]. Therefore,
this aspect of cancer’s meaning to the woman and her
clinician should be addressed as a part of any interven-
tion being prescribed or studied for management of
sexual dysfunctions. That both the clinician and the
BCS have to embrace the same outlook about the BCS’s
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sexual health——namely, that the maintenance of the
woman’s sexual wellness is an important aspect of her
health prescription and should not be relegated to the
column of being unimportant in the overall manage-
ment algorithm.
Another aspect addressed many decades ago regarding
management of sexual issues in the BCS is for the clinician
to be sensitive to the changes in body contour that many
women are left with after treatment and to understand
how the woman has adjusted to these changes. This aspect
of the woman’s overall body image has to be considered
and discussed, regardless of whether lumpectomy, lymph
node dissection, mastectomy, radiation therapy or pharma-
cologic treatment has been carried out. Breast shape and
size may be dramatically changed or an entire breast may
be removed with either reconstruction following this sur-
gery or, in some cases, no reconstruction afterwards. The
absent or reconstructed breast not only changes body
image, but breast and nipple sensation are usually lost or
altered as well. As Huffman noted over 40 years ago, “The
surgery most traumatic to women seems to be mastec-
tomy, because it so vastly changes feminine appearance
and body image” [3]. Ervine further noted, around this
same time period, that the patient’s initial reaction (to
breast cancer treatment) is to feel “…mutilated, repulsed,
desexed, frightened and depressed” [4]. Currently, although
mastectomy is not as prevalent today as it was in the
1960’s when this statement was written in the above text,
these same feelings can reflect how BCS’s feel regardless of
the type of surgery performed. BCS’s deal not only with
loss of a previously healthy breast (or breasts) but also with
the fatigue, hair loss and adverse body functions that result
from the cancer treatment. Giving these women and their
partners the tools that educate them on other sexual
scripts to use during treatment and beyond is a counseling
imperative and should be included and assessed in clinical
trials as well.
In addition to the cancer diagnosis itself and the dis-
figurement that often results, be it mastectomy or
lumpectomy, another issue that will contribute to sex-
ual dysfunction is thrusting the midlife BCS who is
otherwise healthy into the patient role. In the textbook,
Sexual Desire Disorders edited by Leiblum and Rosen
and published in 1988, the issue of the devastating effect
the role of ‘patient’ can have on the sexual functioning of
the patient is discussed [5]. In this book, Bullard writes
that patients , “…may feel compelled to adopt the ‘patient’
role and to comply with institutional and societal prescrip-
tions that a person with a serious medical condition is
‘asexual’ ” [6]. Here again the education and counseling
comes to the forefront in that clinicians must ask patients
how they have reacted to the diagnosis of cancer and then
to counter any negative role ‘scripts’ that the BCS may ex-
press. Education that sexuality does not stop or is not
measured by a medical condition, be it chronic or limited,
is mandatory, even though this new role as ‘patient’ for
the BCS may now require frequent visits to an ambulatory
cancer office or a radiation therapy center or a hospital.
What follows is that all of these issues regarding loss,
altered body image and feelings of non-optimal health
can lead to anxiety, depression, and anger with resultant
secondary sexual dysfunction, such as loss of sexual de-
sire and difficulty with sexual arousal and achieving or-
gasm. With accompanying hormonal changes that may
occur at midlife and that can be exacerbated by some
breast cancer therapies, vaginal dryness and dyspareunia
also can result. Hormonal issues also are of great im-
portance in women who, as a result of family history
undergo genetic testing and then decide to follow a sur-
gical path that reduces their risk. That is, women who
are found to be at high risk for breast or ovarian cancer
can now choose to undergo prophylactic mastectomy
and/or oophorectomy, as Angelina Jolie did. These
women also have to deal with many of the same issues
that women who are diagnosed with breast cancer deal
with—altered body image and/or hormonal issues. Many
women who undergo this type of preventative surgery
are in midlife and, due to the intervention of oophorec-
tomy, immediately become menopausal.
Yes, although we’ve come a long way, as Su et al. note,
in managing sexual dysfunction in BCS’s, we still have a
long way to go regarding high quality data that will pro-
vide us with the tools to optimally manage the sexual is-
sues that often emerge and contribute to expanding
more management options for BCS’s. However, it’s im-
portant to not lose sight of the lessons provided to us
from several decades ago that future management strat-
egies that are implemented and/or studied should be
multifaceted and that pharmacological agents should be
paired with comprehensive education and counseling
interventions.
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